| Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) D Bouhassira, N Attal, H Alchaar, F Boureau, B Brochet, J Bruxelle, ... pain 114 (1-2), 29-36, 2005 | 2127 | 2005 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ... Nature genetics 45 (11), 1353, 2013 | 936 | 2013 |
| Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS) DW Langdon, MP Amato, J Boringa, B Brochet, F Foley, S Fredrikson, ... Multiple Sclerosis Journal 18 (6), 891-898, 2012 | 586 | 2012 |
| Natural history of multiple sclerosis with childhood onset C Renoux, S Vukusic, Y Mikaeloff, G Edan, M Clanet, B Dubois, ... New England Journal of Medicine 356 (25), 2603-2613, 2007 | 562 | 2007 |
| Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. G Edan, D Miller, M Clanet, C Confavreux, O Lyon-Caen, C Lubetzki, ... Journal of Neurology, Neurosurgery & Psychiatry 62 (2), 112-118, 1997 | 529 | 1997 |
| Primary progressive multiple sclerosis. AJ Thompson, CH Polman, DH Miller, WI McDonald, B Brochet, ... Brain: a journal of neurology 120 (6), 1085-1096, 1997 | 514 | 1997 |
| Diagnostic criteria for primary progressive multiple sclerosis: a position paper AJ Thompson, X Montalban, F Barkhof, B Brochet, M Filippi, DH Miller, ... Annals of Neurology: Official Journal of the American Neurological …, 2000 | 454 | 2000 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 377 | 2018 |
| A nationwide survey of migraine in France: prevalence and clinical features in adults P Henry, P Michel, B Brochet, JF Dartigues, S Tison, R Salamon, GRIM Cephalalgia 12 (4), 229-237, 1992 | 368 | 1992 |
| Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte … J Mikita, N Dubourdieu-Cassagno, MSA Deloire, A Vekris, M Biran, ... Multiple Sclerosis Journal 17 (1), 2-15, 2011 | 360 | 2011 |
| Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates SJ Camp, VL Stevenson, AJ Thompson, DH Miller, C Borras, ... Brain 122 (7), 1341-1348, 1999 | 296 | 1999 |
| Brief International Cognitive Assessment for MS (BICAMS): international standards for validation RHB Benedict, MP Amato, J Boringa, B Brochet, F Foley, S Fredrikson, ... BMC neurology 12 (1), 1-7, 2012 | 269 | 2012 |
| Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging C Corot, KG Petry, R Trivedi, A Saleh, C Jonkmanns, JF Le Bas, E Blezer, ... Investigative radiology 39 (10), 619-625, 2004 | 261 | 2004 |
| In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance V Dousset, C Delalande, L Ballarino, B Quesson, D Seilhan, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 1999 | 242 | 1999 |
| Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis MSA Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (4), 519-526, 2005 | 236 | 2005 |
| MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study A Tourbah, C Lebrun-Frenay, G Edan, M Clanet, C Papeix, S Vukusic, ... Multiple Sclerosis Journal 22 (13), 1719-1731, 2016 | 235 | 2016 |
| Neuromyelitis optica in France: a multicenter study of 125 patients N Collongues, R Marignier, H Zephir, C Papeix, F Blanc, C Ritleng, ... Neurology 74 (9), 736-742, 2010 | 232 | 2010 |
| Radiologically isolated syndrome: 5-year risk for an initial clinical event DT Okuda, A Siva, O Kantarci, M Inglese, I Katz, M Tutuncu, BM Keegan, ... PloS one 9 (3), e90509, 2014 | 226 | 2014 |
| Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study A Cobo-Calvo, A Ruiz, E Maillart, B Audoin, H Zephir, B Bourre, J Ciron, ... Neurology 90 (21), e1858-e1869, 2018 | 206 | 2018 |
| Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked … C Lebrun, C Bensa, M Debouverie, S Wiertlevski, D Brassat, J de Seze, ... Archives of neurology 66 (7), 841-846, 2009 | 198 | 2009 |
